Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Annsa C HuangNorah A Terrault

Abstract

Whether direct-acting antivirals (DAAs) increase the risk of hepatocellular carcinoma (HCC) recurrence after tumor-directed therapy is controversial. We sought to determine the impact of DAA therapy on HCC recurrence after local-regional therapy (LRT) and waitlist dropout among liver transplant (LT) candidates with HCC. We performed a retrospective cohort study of 149 LT candidates with hepatitis C virus (HCV) and HCC at a single center from 2014 through 2016. Cumulative incidence of HCC recurrence post-LRT and waitlist dropout was estimated by the DAA group. Factors associated with each outcome were evaluated using competing risks regression. A propensity score stabilized inverse probability weighting approach was used to account for differences in baseline characteristics between groups. The no DAA group (n = 87) had more severe cirrhosis and lower rates of complete radiologic tumor response after LRT than those treated with DAA (n = 62) but had similar alpha-fetoprotein and tumor burden at listing. Cumulative incidence of HCC recurrence within 1 year of complete response after LRT was 47.0% in the DAA group and 49.8% in the no DAA group (P = 0.93). In adjusted competing risk analysis using weighted propensity score modeling,...Continue Reading

References

May 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N Ganne-CarriéM Beaugrand
Jul 9, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Kirti ShettyKim M Olthoff
Aug 9, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Francis Y YaoJohn P Roberts
Feb 23, 2010·Seminars in Liver Disease·Riccardo Lencioni, Josep M Llovet
Mar 15, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Lisa I BackusLarry A Mole
Nov 4, 2011·The Lancet Oncology·Pierre-Alain ClavienUNKNOWN OLT for HCC Consensus Group
Dec 27, 2012·JAMA : the Journal of the American Medical Association·Adriaan J van der MeerHarry L A Janssen
Sep 12, 2013·Circulation. Cardiovascular Quality and Outcomes·M Alan BrookhartTil Stürmer
Jul 22, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Donald G MitchellClaude B Sirlin
Aug 21, 2014·BMC Cancer·Eleonora TerziRita Golfieri
Feb 19, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Francis Y YaoJohn P Roberts
May 20, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bryony SimmonsAndrew Hill
Jan 13, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fred PoordadEugene S Swenson
Feb 2, 2016·Journal of Hepatology·Graham R FosterUNKNOWN HCV Research, UK
Jun 4, 2016·Journal of Hepatology·Calogero CammàAntonio Craxì
Jun 12, 2016·Journal of Hepatology·UNKNOWN ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CirVir and CO23 CUPILT cohorts). Electr
Jul 16, 2016·Journal of Hepatology·Jean-Charles Nault, Massimo Colombo
Sep 2, 2016·Nature Reviews. Gastroenterology & Hepatology·Josep M Llovet, Augusto Villanueva
May 26, 2017·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Alberto ZanettoFrancesco Paolo Russo
May 31, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J LevitskyM Volk
Jun 20, 2017·Journal of Hepatology·Hiroko NagataUNKNOWN Ochanomizu Liver Conference Study Group
Jun 24, 2017·Gastroenterology·Fasiha KanwalHashem B El-Serag

❮ Previous
Next ❯

Citations

Jun 24, 2018·Liver International : Official Journal of the International Association for the Study of the Liver·Giuseppe CabibboAntonio Craxì
Mar 7, 2020·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Federico PiñeroMarcelo Silva
Sep 17, 2020·Expert Review of Gastroenterology & Hepatology·Daniel Hoffman, Neil Mehta
May 13, 2018·Nature Reviews. Gastroenterology & Hepatology·Massimo Colombo, Vincenzo Boccaccio
Jun 7, 2019·Clinical Liver Disease·Feng Su, George N Ioannou
Mar 6, 2019·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Tomomi KogisoKatsutoshi Tokushige
Aug 16, 2019·World Journal of Gastroenterology : WJG·Hadar MeringerLiat Deutsch
Feb 23, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Brian KimNorah A Terrault
Nov 16, 2018·Clinical and Experimental Medicine·Franco DammaccoVito Racanelli
Jul 3, 2018·World Journal of Gastroenterology : WJG·Maria GuarinoUNKNOWN Special Interest Group on “Hepatocellular carcinoma and new anti-HCV therapies” of the Italian Association for the Study of
Mar 30, 2019·Current Hepatology Reports·Feng Su, George N Ioannou
Apr 23, 2020·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Katherine A McGlynnHashem B El-Serag
Dec 17, 2020·Journal of Gastroenterology and Hepatology·Tudor MocanZeno Spârchez
Jul 1, 2020·Clinics and Research in Hepatology and Gastroenterology·Anais Vallet-PichardUNKNOWN AFEF ANRS study group
Nov 28, 2019·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chen-Ta ChiYi-Hsiang Huang
Apr 6, 2020·Transplantation Proceedings·Isolina Baños Pérez, Ana Duca
Jul 28, 2020·JHEP Reports : Innovation in Hepatology·Huiying RaoAnna S Lok
Jan 18, 2020·Current Molecular Pharmacology·Sherin Zakaria, Alaa E El-Sisi
Sep 22, 2020·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.euUNKNOWN Panel members:
Oct 28, 2018·Gastroenterology·Laura Kulik, Hashem B El-Serag

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.